May 13, 2026
Chondroitin Sulfate Sourcing in 2026: What 240 Million Osteoarthritis Patients Mean For Supply
Osteoarthritis affects over 240 million people worldwide. And the number of people over 60 is set to double by 2050. Here's what that means for the chondroit...
-
Dec 11, 2025Hangzhou Jeci Biochem Technology Co., Ltd. Can Supply Advanced Intermediates ...Hangzhou Jeci Biochem Technology Co., Ltd. can supply advanced intermediates of Iptacopan (CAS: 1644667‑61‑7, CAS: 1481631‑51‑9, CAS: 2803364‑77‑2,...view more -
Dec 02, 2025The First ASI Antihypertensive Drug Is On Its Way! AstraZeneca’s Baxdrostat R...Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredient...view more -
Dec 02, 2025Breaking Into The Ten-Billion-Yuan Diabetes Market! First Generic Of Linaglip...Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredient...view more -
Nov 17, 2025GBD 2023 Data Released! Global Health Landscape Undergoes Pivotal ShiftsA comprehensive update on global health trends from 2010 to 2023 reveals key findings from the GBD 2023 study: - Significant decline in infectious,...view more -
Nov 12, 2025The IgA Nephropathy Field Is Gaining MomentumFrom November 5 to 9, local time, the 58th American Society of Nephrology (ASN) Kidney Week 2025 was held in Houston, Texas. As a premier global ac...view more -
Nov 07, 2025$9.9 Billion Prostate Cancer Drug Approved( A Breakthrough in Nuclear Medicine)On November 5 , Novartis announced that its radioligand therapy (RLT) drug Pluvicto (lutetium [177Lu] vipivotide tetraxetan) received simultane...view more -
Oct 29, 2025World's First PROTAC Drug Submission: Targeted Degradation Ushers in A New Era!Recently, Arvinas and Pfizer announced that they have submitted a New Drug Application (NDA) to the U.S. FDA for Vepdegestrant, intended for the tr...view more -
Oct 10, 2025New Breakthroughs in Targeted Therapy For Gastrointestinal Cancers In the field of gastrointestinal (GI) cancer treatment, target research remains the core direction for breaking through efficacy bottlenecks. C...view more -
Sep 30, 2025Another Pharma Giant Terminates AAV Gene Therapy BusinessAccording to foreign media reports, Biogen has discontinued all gene therapy programs based on adeno-associated virus (AAV) capsids. In fact, Bioge...view more -
Sep 28, 2025Impending 100% US Drug Tariff: What's The Impact On WuXi AppTec?Introduction: True globalization means having production capacity ready where clients need it, ahead of time.view more -
Sep 26, 2025Notice Regarding National Day Holiday Arrangements For 2025Dear Valued Customer, Greetings! On the occasion of the upcoming National Day holiday, the entire team at HANGZHOU JECI extends our warmest holiday...view more -
Sep 25, 2025Gilead Expands Cell Therapy Footprint With $350M Cash Acquisition Of Interi...Cell therapy, as an innovative frontier in biopharma, is advancing at a remarkable pace. While traditional CAR-T therapies have achieved groundb...view more